FDA Vaccine Advisory Committee to Determine 2025-2026 COVID-19 Vaccine Formulation

FDA Vaccine Advisors To Meet for COVID-19 Vaccine Updates

The FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet on May 22, 202512

The meeting will run from 8:30 a.m. to 4:
30 p.m. ET1
The committee will discuss and make recommendations on selecting the 2025-2026 formula for COVID-19 vaccines in the United States12
All participants will join through online teleconferencing/video conferencing platforms1
The committee's recommendations are non-binding, but the FDA typically follows their advice15
The meeting occurs amid potential increased scrutiny from the Department of Health and Human Services regarding booster development and approval processes5
Background materials will be made available to the public no later than 2 business days before the meeting1
The meeting announcement was posted in the Federal Register on Thursday, May 8, 20252

Sources:

1. https://www.fda.gov/advisory-committees/advisory-committee-calendar/vaccines-and-related-biological-products-advisory-committee-may-22-2025-meeting-announcement

2. https://www.federalregister.gov/documents/2025/05/08/2025-08083/vaccines-and-related-biological-products-advisory-committee-notice-of-meeting-establishment-of-a

5. https://www.biopharmadive.com/news/fda-vaccine-advisers-meeting-covid-formula/747376/

Leave a Reply

Your email address will not be published. Required fields are marked *